Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-28T08:00:38.995Z Has data issue: false hasContentIssue false

36 - Post-traumatic stress disorders and adjustment disorders

from Part III - Specific treatments

Published online by Cambridge University Press:  12 May 2010

By
Randall D. Marshall ,
Steven B. Rudin  and
Peter Tyrer
Edited by
Peter Tyrer  and
Kenneth R. Silk
Randall D. Marshall
Affiliation:
New York State Psychiatric Institute NY USA
Steven B. Rudin
Affiliation:
New York State Psychiatric Institute New York, NY USA
Peter Tyrer
Affiliation:
Imperial College London Claybrook Centre Charing Cross Campus London UK
Peter Tyrer
Affiliation:
Imperial College of Science, Technology and Medicine, London
Kenneth R. Silk
Affiliation:
University of Michigan, Ann Arbor
Get access

Summary

Editor's note

Stress reactions run from Acute Stress Reactions and Adjustment Disorders to Post-traumatic Stress Disorder (PTSD). The first two, in many instances, may be thought of as time limited in their impact and respond to many different types of psychosocial interventions. The primary purpose of intervening in these disorders is to facilitate more effecting coping with the stressor, reduce functional impairment, and return the individual to his previous level of active functioning in the community. PTSD has been shown to respond to both trauma-focused cognitive-behavioral psychotherapies and to pharmacological agents, particularly the SSRIs, though other pharmacologic interventions may impact some of the disturbed affect, anxiety, and lability, and to psychosocial interventions. As with many other disorders, there is a treatment resistant group that remain significantly impaired despite treatment, and long-term management of symptoms becomes the primary goal.

Introduction: differences in classification of stress disorders

The adjustment disorders, acute stress disorder, and post-traumatic stress disorder (DSM-IV) all share the common feature of occurring as a response to an adverse environmental event or cluster of events. The distinction appears clear cut; post-traumatic stress disorders follow extreme stressors that are operationally defined, whereas adjustment disorders may follow any kind of stressor of a less serious degree.

Adjustment disorders are defined as “clinically significant emotional or behavioral symptoms in response to an identifiable psychosocial stressor or stressors” (DSM-IV), and must develop within 3 months of the stressor (DSM-IV).

Type
Chapter
Information
Cambridge Textbook of Effective Treatments in Psychiatry , pp. 588 - 610
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anderson, I. M., Nutt, D. J. & Deakin, J. F. (2000). Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. Journal of Psychopharmacology, 14, 3–20.Google Scholar
Baker, D. G., Diamond, B. I., Gillette, G.et al. (1995). A double-blind randomized placebo-controlled multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology, 122, 386–9.Google Scholar
Bills, L. J. & Kreisler, K. (1993). Treatment of flashbacks with naltrexone. American Journal of Psychiatry, 150, 1430.Google Scholar
Blanchard, E. B., Buckley, T. C., Hickling, E. J. & Taylor, A. E. (1998). Posttraumatic Stress disorder and comorbid major depression: is the correlation an illusion?Journal of Anxiety Disorder, 12, 21–37.Google Scholar
Brady, K. T., Sonne, S. C. & Roberts, J. M. (1995). Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. Journal of Clinical Psychiatry, 56(11), 502–5.Google Scholar
Brady, K., Pearlstein, T., Asnis, G. M.et al. (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. Journal of the American Medical Association, 283, 1837–44.Google Scholar
Braun, P., Greenberg, D., Dasberg, H. & Lerer, B. (1990). Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. Journal of Clinical Psychiatry, 51, 236–8.Google Scholar
Breslau, N., Davis, G. C., Andreski, P. & Peterson, E. (1991). Traumatic events and posttraumatic stress disorder in an urban population of young adults. Archives of General Psychiatry, 48(3), 216–22.Google Scholar
Brophy, M. H. (1991). Cyproheptadine for combat nightmares in post-traumatic stress disorder and dream anxiety disorder. Military Medicine, 156, 100–1.Google Scholar
Bryant, R. A., Harvey, A. G., Dang, S. T., Sackville, T. & Basten, C. (1998). Treatment of acute stress disorder: a comparison of cognitive-behavioral therapy and supportive counseling. Journal of Consulting and Clinical Psychology, 66, 862–6.CrossRefGoogle Scholar
Bryant, R. A. (2003). Early predictors of post-traumatic stress disorder. Biological Psychiatry, 53, 789–95Google Scholar
Bryant, R. A., Sackville, T., Dang, S. T., Moulds, M. & Guthrie, R. (1999). Treating acute stress disorder: an evaluation of cognitive behavior therapy and supportive counseling techniques. American Journal of Psychiatry, 11, 1780–6.Google Scholar
Bryant, R. A., Harvey, A. G., Guthrie, R. M. & Moulds, M. L. (2000). A prospective study of psychophysiological arousal, acute stress disorder, and posttraumatic stress disorder. Journal of Abnormal Psychology, 109, 341–4.Google Scholar
Boudewyns, P. A., Albrecht, J. W., Talbert, F. S. & Hyer, L. A. (1991). Comorbidity and treatment outcome of inpatients with chronic combat-related PTSD. Hospital and Community Psychiatry, 42(8), 847–849.Google Scholar
Burton, J. K. & Marshall, R. D. (1999). Categorizing fear: the role of trauma in clinical formulation. American Journal of Psychiatry, 156(5), 761–6.Google Scholar
Butterfield, M. I., Becker, M. E., Connor, K. M., Sutherland, S., Churchill, L. E. & Davidson, J. R. (2001). Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. International Clinical Psychopharmacology, 16(4), 197–203.Google Scholar
Cahill, S. P., Foa, E. B., Hembree, E. A., Marshall, R. D. & Nacash, N. (2006). Dissemination of exposure therapy in the treatment of PTSD. Journal of Traumatic Stress, 19(5), 1–14.Google Scholar
Casey, P. R., Tyrer, P. & Platt, S. (1985). The relationship between social functioning and psychiatric symptomatology in primary care. Social Psychiatry, 20, 5–9.Google Scholar
Chemtob, C. M., Novaco, R. W., Hamada, R. S. & Gross, D. M. (1997). Cognitive-behavioral treatment for severe anger in posttraujatic stress disorder. Journal of Consulting and Clinical Psychology, 65, 184–9.Google Scholar
Chung, M. Y., Min, K. H., Jun, Y. J., Kim, S. S., Kim, W. C. & Jun, E. M. (2004). Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Human Psychopharmacology, 19(7), 489–94.Google Scholar
Cloitre, M., Cohen, L. R., Koenen, K. C. & Han, H. (2002). Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. Journal of Consult Clinical Psychology, 70, 1067–74.Google Scholar
Connor, K. M., Davidson, J. R., Weisler, R. H. & Ahearn, E. (1999). A pilot study of mirtazapine in post-traumatic stress disorder. International Clinical Psychopharmacology, 14(1), 29–31.Google Scholar
Cooper, N. A. & Clum, G. A. (1989). Imaginal flooding as a supplementary treatment for PTSD in combat veterans: a controlled study. Behavior Therapy, 20, 381–91.CrossRefGoogle Scholar
Davidson, J. R. (2004). Remission in post-traumatic stress disorder (PTSD): effects of sertraline as assessed by the Davidson Trauma Scale, Clinical Global Impressions and the Clinician Administered PTSD scale. International Clinical Psychopharmacology, 19(2), 85–7.Google Scholar
Davidson, P. R. & Parker, K. C. (2001). Eye movement desensitization and reprocessing (EMDR): a meta-analysis. Journal of Consulting and Clinical Psychology, 69, 305–16.Google Scholar
Davidson, J., Kudler, H., Smith, R.et al. (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Archives of General Psychiatry, 47, 259–66.Google Scholar
Davidson, J. R. T., Hughes, D., Blazer, D. & George, L. K. (1991a). Posttraumatic stress disorder in the community: an epidemiological study. Psychological Medicine, 2, 1–19.Google Scholar
Davidson, J., Pearlstein, T., Londborg, P.et al. (2001b). Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. American Journal of Psychiatry, 158, 12, 1974–81.Google Scholar
Davidson, J. R., Rothbaum, B. O., Kolk, B., Sikes, C. R. & Farfel, G. M. (2001d). Multi-center double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Archives of General Psychiatry, 58, 485–92.Google Scholar
Davidson, J. R., Weisler, R. H., Butterfield, M. I.et al. (2003). Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biological Psychiatry, 53 (2), 188–91.Google Scholar
Davidson, J., Rothbaum, B. O., Tucker, P., Asnis, G., Benattia, I. & Musgnung, J. J. (2006a). Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. Journal of Clinical Psychopharmacology, 26(3), 259–67.Google Scholar
Davidson, J., Baldwin, D., Stein, D. J.et al. (2006b). Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Archives of General Psychiatry, 63(10), 1158–65.Google Scholar
Davis, L. L., Nugent, A. L., Murray, J., Kramer, G. L. & Petty, F. (2000). Nefazodone treatment for chronic posttraumatic stress disorder: an open trial. Journal of Clinical Psychopharmacology, 20(2), 159–64.CrossRefGoogle Scholar
Devilly, G. J. & Spence, S. H. (1999). The relative efficacy and treatment distress of EMDR and a cognitive-behavior trauma treatment protocol in the amelioration of posttraumatic stress disorder. Journal of Anxiety Disorders, 13(1–2), 131–57.Google Scholar
Dunner, D. L., Ishiki, D., Avery, D. H., Wilson, L. G. & Hyde, T. S. (1986). Effects of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. Journal of Clinical Psychiatry, 47, 458–460.Google Scholar
Famularo, R., Kinscherff, R. & Fenton, T. (1998). Propranolol treatment for childhood post-traumatic stress disorder, acute type: a pilot study. American Journal of Diseases of Children, 142, 1244–7.Google Scholar
Foa, E. B., Rothbaum, R. O., Riggs, D. S. & Murdock, T. B. (1991). Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. Journal of Consulting and Clinical Psychology, 59, 715–23.Google Scholar
Foa, E. B., Hearst-Ikeda, D. & Perry, K. J. (1995). Evaluation of a brief cognitive-behavioral program for the prevention of chronic PTSD in recent assault victims. Journal of Consulting and Clinical Psychology, 63, 948–55.Google Scholar
Foa, E. B., Dancu, C. V., Hembree, E. A., Jaycox, L. H., Meadows, E. A. & Street, G. P. (1999a). A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. Journal of Consulting and Clinical Psychology, 67, 194–200.Google Scholar
Foa, E. B., Davidson, J. R. T. & Frances, A. (1999b). The expert consensus guideline series: treatment of posttraumatic stress disorder. Journal of Clinical Psychiatry, 60 (Suppl.) 16, 1–76.Google Scholar
Galea, S., Ahern, J., Resnick, H.et al. (2002). Psychological sequelae of the September 11 terrorist attacks in New York City. New England Journal of Medicine, 346, 982–7.Google Scholar
Garfield, D. A., Fichtner, C. G., Leveroni, C. & Mahableshwarkar, A. (2001). Open trial of nefazodone for combat veterans with posttraumatic stress disorder. Journal of Traumatic Stress, 14(3), 453–60.CrossRefGoogle Scholar
Gelpin, E., Bonne, O., Peri, T., Brandes, D. & Shalev, A. Y. (1996). Treatment of recent trauma survivors with benzodiazepines: a prospective study. Journal of Clinical Psychiatry, 57(9), 390–4.Google Scholar
Glover, H. (1993). A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder. Israel Journal of Psychiatry and Related Sciences, 30(4), 255–63Google Scholar
Gupta, S., Austin, R., Cali, L. A. & Bhatara, V. (1998a). Nightmares treated with cyproheptadine. Journal of the American Academy of Child and Adolescent Psychiatry, 37(6), 570–2.Google Scholar
Gupta, S., Popli, A., Bathhurst, E., Hennig, L., Droney, T. & Keller, P. (1998b). Efficacy of cyproheptadine for nightmares associated with posttraumatic stress disorder. Comprehensive Psychiatry, 39(3), 160–4.Google Scholar
Harmon, R. J. & Riggs, P. D. (1996). Clonidine for posttraumatic stress disorder in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1247–9.CrossRefGoogle Scholar
Harsch, H. H. (1986). Cyproheptadine for recurrent nightmares. American Journal of Psychiatry, 143, 1491–2.CrossRefGoogle Scholar
Herman, J. (1997). “A forgotten history.” in Trauma and Recovery: The Aftermath pf Violence – from Domestic Abuse to Political Terror, pp. 7–32. New York: BasicBooks.
Hertzberg, M. A., Feldman, M. E., Beckham, J. C. & Davidson, J. R. (1996). Trial of trazadone for posttraumatic stress disorder using a multiple baseline group design. Journal of Clinical Psychopharmacology, 16(4), 294–8.Google Scholar
Hertzberg, M. A., Butterfield, M. I., Feldman, M. E.et al. (1999). A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biological Psychiatry, 45, 1226–9.Google Scholar
Hertzberg, M. A., Feldman, M. E., Beckham, J. C., Kudler, H. S. & Davidson, J. R. (2000). Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Annals of Clinical Psychiatry, 12(2), 101–5.Google Scholar
Hidalgo, R., Hertzberg, M. A., Mellman, T.et al. (1999). Nefazodone in post-traumatic stress disorder: results from six open-label trials. International Journal of Clinical Psychopharmacology, 14(2), 61–8.Google Scholar
Hogben, G. L. & Cornfield, R. B. (1981). Treatment of neurotic war neurosis with phenelzine. Archives of General Psychiatry, 38, 440–5.Google Scholar
Horrigan, J. P. (1996). Guanfacine for PTSD nightmares. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 975–6.CrossRefGoogle Scholar
Jaycox, L. H., Foa, E. B. & Morral, A. R. (1998). Influence of emotional engagement and habituation on exposure therapy for PTSD. Journal Consulting Clinical and Psychology, 66, 185–192.Google Scholar
Jones, R., Yates, W., Williams, S., Zhou, M., & Hardman, L. (1999). Outcome for adjustment disorder with depressed mood: comparison with other mood disorders. Journal of Affective Disorders, 55, 55–61.Google Scholar
Ibarra, P., Bruehl, S. P., McCubbin, J. A.et al. (1994). An unusual reaction to opioid blockade with naltrexone in a case of post-traumatic stress disorder. Journal of Traumatic Stress, 7(2), 303–9.Google Scholar
Katz, R. J., Lott, M. H., Arbus, P.et al. (1995). Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety, 1, 169–74.CrossRefGoogle Scholar
Keane, T. M., Fairbank, J. A., Caddell, J. M. & Zimmering, R. T. (1989). Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behavior Therapy, 20, 245–60.CrossRefGoogle Scholar
Kessler, R. C., Sonnega, A., Bromet, E., Hughes, M. & Nelson, C. B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52, 1048–60.Google Scholar
Kitchner, L. & Greenstein, R. (1985). Low dose lithium carbonate in the treatment of post traumatic stress disorder: brief communication. Military Medicine, 150, 378–81.Google Scholar
Klein, D. F. (1978). A proposed definition of mental illness. In Critical Issues in Psychiatric Diagnosis, ed. Spitzer, R. L., & Klein, D. F., New York: Raven Press.
Kolb, L. C., Burris, B. C. & Griffiths, S. (1984). Propranolol and clonidine in the treatment of the chronic post-traumatic stress disorders of war. In Post-traumatic Stress Disorder: Psychological and Biological Sequelae, ed. Kolk, B. A., pp. 98–105. Washington, DC: American Psychiatric Press.
Kosten, T. R., Frank, J. B., Dan, E., McDougle, C. J. & Giller, E. L. (1991). Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. Journal of Nervous and Mental Disease, 179, 366–70.Google Scholar
Kosten, T. R., Mason, J. W., Giller, E. L., Ostroff, R. B. & Harkness, L. (1987). Sustained urinary norepinephrine and epinephrine elevation in posttraumatic stress disorder. Psychoneuroendocrinology, 12, 13–20.CrossRefGoogle Scholar
Krashin, D. & Oates, E. W. (1999). Risperidone as an adjunct therapy for post-traumatic stress disorder. Military Medicine, 164(8), 605–6.Google Scholar
Leyba, C. M. & Wampler, T. P. (1998). Risperidone in PTSD. Psychiatric Service, 49(2), 245–6.Google Scholar
Lowenstein, R. J., Hornstein, N. & Farber, B. (1988). Open trial of clonazepam in post-traumatic stress symptoms in multiple personality disorder. Dissociation, 1, 3–12.Google Scholar
Marks, I., Lovell, K., Noshirvani, H., Livanou, M. & Thrasher, S. (1998). Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring. Archives of General Psychiatry, 55, 317–25.Google Scholar
Marshall, R. D. & Klein, D. F. (1995). Pharmacotherapy in the treatment of Posttraumatic Stress Disorder. Psychiatric Annals, 25, 588–97.CrossRefGoogle Scholar
Marshall, R. D. & Garakani, A. (2002). Psychobiology of the acute stress response and its relationship to the psychobiology of post-traumatic stress disorder. Psychiatric Clinics of North America, 25, 385–95.Google Scholar
Marshall, R. D., & Klein, D. F. (2002). Conceptual antecedents of the Anxiety Disorders. In Anxiety, ed. Nutt, D. J. & Ballenger, J. C.. Oxford: Blackwell Science Limited.
Marshall, R. D., Spitzer, R. & Liebowitz, M. R. (1999). A Review and critique of the new DSM-IV diagnosis of acute stress disorder. American Journal of Psychiatry, 156, 1677–85.Google Scholar
Marshall, R. D., Olfson, M., Hellman, F., Blanco, C., Guardino, M., Struening, E. (2001a). Comorbidity, impairment and suicidality in subthreshold PTSD. American Journal of Psychiatry, 158: 1467–73Google Scholar
Marshall, R. D., Beebe, K. L., Oldham, M, and Zaninelli, R (2001b). Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. American Journal of Psychiatry, 158(12), 1982–88.Google Scholar
Marshall, R. D., Blanco, C., Printz, D., Liebowitz, M. R., Klein, D. F. & Coplan, J. (2002). Noradrenergic and HPA axis functioning in PTSD vs. Panic Disorder. Psychiatry Research, 110(3), 219–30.CrossRefGoogle Scholar
Marshall, R. D., Lewis-Fernandez, R., Blanco, C.et al. (2006). A controlled trial of Paroxetine for chronic PTSD, dissociation and interpersonal problems in urban, mostly minority adults. Depression and Anxiety, 0, 1–8.Google Scholar
Mellman, T. A., Byers, P. M. & Augenstein, J. S. (1998). Pilot evaluation of hypnotic medication during acute traumatic stress response. Journal of Traumatic Stress, 11, 563–9.Google Scholar
Martenyi, F.Brown, E. B.. Zhang, H., Prakash, A. & Koke, S. C. (2002). Fluoxetine versus placebo in posttraumatic stress disorder. Journal of Clinical Psychiatry, 63(3), 199–206.CrossRefGoogle Scholar
Monnelly, E. P. & Ciraulo, D. A. (1999). Risperidone effects on irritable aggression in posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 19(4), 377–8.Google Scholar
Mueser, K. T., Rosenberg, S. D., Goodman, L. A. & Trumbetta, S. L. (2002). Trauma, PTSD, and the course of severe mental illnesss: an interactive model. Schizophrenia Research, 53, 123–43.Google Scholar
Neal, L. A., Shapland, W. & Fox, C (1997). An open trial of moclobemide in the treatment of post-traumatic stress disorder. International Clinical Psychopharmacology, 12, 231–237.CrossRefGoogle Scholar
Otte, C., Wiedemann, K., Yassouridis, A. & Kellner, M. (2004). Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study. Journal of Clinical Psychopharmacology, 24(1), 106–8.CrossRefGoogle Scholar
Pitman, R. K. & Delahanty, D. L. (2005). Conceptually driven pharmacologic approaches to acute trauma. CNS Spectrums, 10, 99–106.Google Scholar
Pitman, R. K., Kolk, B. A., Orr, S. P. & Greenberg, M. S. (1990). Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. Archives of General Psychiatry, 47, 541–4.Google Scholar
Pitman, R. K., Altman, B., Greenwald, E.et al. (1991). Psychiatric complications during flooding therapy for posttraumatic stress disorder. Journal of Clinical Psychiatry, 52, 17–20.Google Scholar
Pitman, R. K., Sanders, K. M., Zusman, R. M.et al. (2002). Pilot study of secondary prevention of posttraumatic stress disorder with propanolol. Biological Psychiatry, 51, 189–92.CrossRefGoogle Scholar
Petty, F., Brannan, S., Casada, J.et al. (2001). Olanzapine treatment for post-traumatic stress disorder: an open-label study. International Clinical Psychopharmacology, 16, 331–7.CrossRefGoogle Scholar
Reich, D. B.Winternitz, S.Hennen, J.Watts, T. & Stanculescu, C. (2004). A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. Journal of Clinical Psychiatry, 65(12),1601–6.CrossRefGoogle Scholar
Reist, C., Kauffman, C. D., Haier, R. J.et al. (1989). A controlled trial of desipramine in 18 men with posttraumatic stress disorder. American Journal of Psychiatry, 146, 513–16.Google Scholar
Resick, P. A., Nishith, P., Weaver, T. L., Astin, M. C. & Feuer, C. A. (2002). A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. Journal of Consulting Clinical Psychology, 70, 867–79.Google Scholar
Riggs, D. S., Byrne, C. A., Weathers, F. W. & Litz, B. T. (1998). The quality of the intimate relationships of male Vietnam veterans: problems associated with posttraumatic stress disorder. Journal of Traumatic Stress, 11, 87–101.Google Scholar
Risse, S. C., Whitters, A., Burke, J., Chen, S., Scurfield, R. M. & Raskind, M. A. (1990). Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder. Journal of Clinical Psychiatry, 51(5), 206–9.Google Scholar
Rothbaum, B. O., Astin, M. C. & Marsteller, F. (2005). Prolonged exposure therapy versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. Journal of Traumatic Stress, 18, 607–16.Google Scholar
Scott, M. J. & Stradling, S. G. (1997). Client compliance with exposure treatments for Posttraumatic Stress Disorder. Journal of Traumatic Stress, 10, 523–6.CrossRefGoogle Scholar
Seivewright, H., Tyrer, P. & Johnson, T. (1998). Prediction of outcome in neurotic disorder: a five year prospective study. Psychological Medicine, 28, 1149–57.Google Scholar
Sernyak, M. J., Kosten, T. R., Fontana, A. & Rosenheck, R. (2001). Neuroleptic use in the treatment of post-traumatic stress disorder. Psychiatric Quarterly, 72(3), 192–213.Google Scholar
Shalev, A. Y., Sahar, T., Freedman, S.et al. (1998). A prospective study of the heart rate response following trauma and the subsequent development of posttraumatic stress disorder. Archives of General Psychiatry, 55, 553–9.Google Scholar
Shestazky, M., Greenberg, D. & Lerer, B. (1987). A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatric Research, 24, 149–55.Google Scholar
Smajkic, A., Weine, S., Djuric-Bijedic, Z., Boskailo, E., Lewis, J. & Pavkovic, I. (2001). Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. Journal of Traumatic Stress, 14(3), 445–52.Google Scholar
Spitzer, R. L., First, M. B. & Wakefield, J. C. (2007). Saving PTSD from itself in DSM-V. Journal of Anxiety Disorders, 21, 233–41.Google Scholar
Stirman, S. W., DeRubeis, R. J., Crits-Christoph, P. & Brody, P. E. (2003). Are samples in randomized controlled trials of psychotherapy representative of community outpatients? A new methodology and initial findings. Journal of Consulting and Clinical Psychology, 71, 963–72.Google Scholar
Strain, J. J., Smith, G. C., Hammer, J. S.et al. (1998). Adjustment disorder: a multi-site study of its utilization and interventions in the consultation-liaison psychiatry setting. General Hospital Psychiatry, 20: 139–49.Google Scholar
Tarrier, N., Pilgrim, H., Sommerfield, C.et al. (1999). A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. Journal of Consulting and Clinical Psychology, 67, 13–18.Google Scholar
Tucker, P., Zaninelli, R., Yehuda, R., Ruggiero, L., Dillingham, K. & Pitts, C. D. (2001). Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. Journal of Clinical Psychiatry, 62(11), 86–868.Google Scholar
Tyrer, P., Seivewright, N., Murphy, S.et al. (1988). The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet, ii, 235–40.Google Scholar
Tyrer, P., Seivewright, H. & Johnson, T. (2005). Long-term outcome of anxiety and depressive disorders: the Nottingham Study of Neurotic Disorder. Directions in Psychiatry, 25, 269–80.Google Scholar
Vaiva, G., Ducrocq, F., Jezequel, K.et al. (2003). Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biological Psychiatry, 54, 947–9.Google Scholar
Klink, J. J. L., Blonk, R. W. B., Schene, A. H. & Dijk, F. J. H. (2003). Reducing long term sickness absence by an activating intervention in adjustment disorders: a cluster randomized controlled design. Occupational and Environmental Medicine, 60, 429–37.Google Scholar
Vermetten, E. & Bremner, J. D. (2002). Circuit and systems in stress II. Applications to neurobiology and treatment in posttraumatic stress disorder. Depression and Anxiety, 16, 14–38.Google Scholar
Yehuda, R., Marshall, R. M., Penkower, A. & Wong, C. M. (2002). Pharmacological treatments for posttraumatic stress disorder. In A Guide to Treatments that Work, 2nd edn, ed. Nathan, P. E. & Gorman, J. M., pp. 411–45. New York: Oxford University Press.
Yehuda, R., Southwick, S. M. & Giller, E. L. (1992). Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. Journal of Nervous and Mental Disease, 180, 321–5.Google Scholar
Zisook, S., Chentsova-Dutton, Y. E., Smith-Vaniz, A.et al. (2000). Nefazodone in patients with treatment-refractory posttraumatic stress disorder. Journal of Clinical Psychiatry, 61(3), 203–8.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×